5th Annual Hematologic Malignancies Symposium
This symposium will bring together recognized national and international speakers to address recent advances in diagnosis of myelodysplastic syndrome (MDS) and measurable residual disease [MRD] directed acute myelogenous leukemia (AML) therapy. During our symposium, we will emphasize the need for physicians to combine up-to-date knowledge and technology to efficiently identify “actionable targets” for treatment of AML and MDS patients. Additionally, we expect to gain insight into promising scientific data that would inform therapy efficacy based on AML MRD evaluation. The symposium will provide important novel development in MDS and AML pathogenesis leading to unique opportunity for clinical trial design ideas.
Hematologists, primary care physicians, nurses, nurse practitioners, physician assistants, medical trainees and students
At the conclusion of the conference, participants should be able to:
- Summarize current principles that explain clonal hematopoiesis and acute myelogenous leukemia (AML).
- Describe the current role of targeted clonal hematopoiesis and AML genome.
- Integrate complex clonal hematopoiesis and AML into genomic and therapeutic algorithms.
- Discuss the role of targeted agents in the treatment of clonal hematopoiesis and AML in genomic and therapeutic algorithms.
Lecture, Small Group Breakout Session, and Panel Discussion
Evaluation by questionnaire will address program content, presentation, and possible bias.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC CREDIT
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participant will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Cizik School of Nursing at UTHealth is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 4.50 contact hours of nursing continuing education (CNE).
- 4.50 ABIM MOC II
- 4.50 AMA PRA Category 1 Credit™
- 4.50 ANCC
- 4.50 Attendance